Invesco Biotechnology & Genome ETF (PBE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBE | VHT | IBB | ||
| Company | Invesco Biotechnology & Genome ETF | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 76.79 | 267.12 | 161.79 | ||
| High | 77.03 | 267.80 | 162.95 | ||
| Low | 76.74 | 265.62 | 160.56 | ||
| Latest | 76.85 | 266.36 | 161.86 | ||
| Change | +1.26 | +1.00 | +1.45 | ||
| % Change | +1.66% | +0.38% | +0.90% | ||
| Volume | 2,100 | 124,900 | 1,497,500 | ||
| 20-Day Average Volume | 8,890 | 206,345 | 1,775,835 | ||
| Previous Close | 75.60 | 265.36 | 160.41 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 77.62 | 276.64 | 166.36 | ||
| 20-Day Raw Stochastic | 26.32% | 5.31% | 15.16% | ||
| 20-Day Relative Strength | 43.35 | 33.24 | 41.48 | ||
| Weighted Alpha | +24.21 | +5.34 | +31.36 | ||
| Today's Opinion | 24% Sell | 40% Sell | 8% Sell | ||
| Previous Opinion | 24% Sell | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/23/26 | -1.15% since 03/23/26 | -0.51% since 03/23/26 | ||
| Low | 75.50 on 03/27/26 | 264.97 on 03/27/26 | 159.68 on 03/24/26 | ||
| High | 78.42 on 03/25/26 | 272.66 on 03/26/26 | 166.98 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -6.25% since 02/27/26 | -9.86% since 02/27/26 | -7.70% since 02/27/26 | ||
| Low | 75.50 on 03/27/26 | 264.97 on 03/27/26 | 159.68 on 03/24/26 | ||
| High | 81.48 on 03/02/26 | 294.47 on 03/02/26 | 174.74 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | -8.31% since 12/26/25 | -8.37% since 12/26/25 | -5.91% since 12/26/25 | ||
| Low | 75.50 on 03/27/26 | 264.97 on 03/27/26 | 159.68 on 03/24/26 | ||
| High | 85.73 on 01/07/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| 6-Month | |||||
| %Chg | +12.06% since 09/26/25 | +5.20% since 09/26/25 | +14.83% since 09/26/25 | ||
| Low | 68.75 on 09/30/25 | 251.90 on 09/29/25 | 140.83 on 09/29/25 | ||
| High | 85.73 on 01/07/26 | 298.61 on 01/07/26 | 179.64 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 246,698 | 16,026,880 | 8,012,070 | ||
| Shares Outstanding, K | 3,210 | 60,170 | 49,500 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.79 | 0.67 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.082 on 03/23/26 | 0.994 on 03/24/26 | 0.122 on 03/17/26 | ||
| Next Ex-Dividends Date | 03/23/26 | 03/24/26 | 03/17/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 14.96 | 24.40 | 26.01 | ||